Using immunotherapy can reduce risk of returning skin cancer - Study

A new study shows using an immunotherapy can significantly reduce the risk of a patient's skin cancer returning.

Nearly two thirds of of patients treated with nivolumab at an earlier stage alongside surgery, experienced recurrence-free survival.

Anne Gribben from Dublin was diagnosed with stage three malignant melanoma in 2006 and is still cancer-free as a result of the treatment.

She was given one of two drug treatment options and says her health has been great since.

She said: "The results have been good because everything has been clear since and I started that in 2015."

File image.

- Digital Desk

More in this Section

Jet makes emergency landing in Shannon after passenger falls ill

Gardaí confirm remains found 17 years ago belong to missing Aengus 'Gussie' Shanahan

Supreme Court to decide if Catherine Nevin's murder conviction can be used to disinherit her estate

More work needed to disrupt paramilitarism in Northern Ireland – watchdog

Breaking Stories

Tried and tested: Polar’s new Vantage M running watch

7 design hacks to enhance your garden as the nights draw in

Ask a counsellor: ‘I’m scared my messy relationship history will put my new partner off me’

Whole world in their hands: Icons design globes in aid of GOAL

More From The Irish Examiner